Ms Adrienne Kirby

Biostatistician
Medicine, Sydney Medical School
NHMRC Clinical Trials Centre

Telephone +61 2 9562 5064
Fax +61 2 9565 1863

Map

Selected grants

2012

  • Pathogenesis and risk assessment of coronary artery disease; Simes R, Kirby A, Meikle P; National Health and Medical Research Council (NHMRC)/Project Grants.

2011

  • Surgery for the Treatment of Otitis Media in Indigenous Australian; O'Leary S, Coates H, Morris P, Kong K, Kirby A, Perry C; National Health and Medical Research Council (NHMRC)/Project Grants.

2010

  • AUSSPRINT: Australian study of the effects of strict potassium restriction on neuropathy in chronic kidney disease; Krishnan A, Kiernan M, Kirby A, Pussell B; National Health and Medical Research Council (NHMRC)/Project Grants.

2006

  • Is non-invasive management of dental caries in private practice cost-effective? A randomized controlled trial; Evans W, Schwarz E, Pollicino C, Kirby A; National Health and Medical Research Council (NHMRC)/Project Grants.

Selected publications

Download citations: PDF RTF Endnote

Book Chapters

  • Keech, A., Gebski, V., Kirby, A. (2007). Determining the sample size in a clinical trial. In Anthony Keech, Val Gebski, Rhana Pike (Eds.), Interpreting and reporting clinical trials: a guide to the CONSORT statement and the principles of randomised controlled trials, (pp. 28-38). Sydney: AMPCo.

Journals

  • Simes, R., Becattini, C., Agnelli, G., Eikelboom, J., Kirby, A., Mister, R., Prandoni, P., Brighton, T. (2014). Aspirin for the Prevention of Recurrent Venous Thromboembolism: The INSPIRE Collaboration. Circulation (Baltimore), 130(13), 1062-1071. [More Information]
  • Glasziou, P., Irwig, L., Kirby, A., Tonkin, A., Simes, R. (2014). Which lipid measurement should we monitor? An analysis of the LIPID study. BMJ Open, 4(2), e003512. [More Information]
  • Wolgemuth, J., Savage, R., Helmer, J., Harper, H., Lea, T., Abrami, P., Kirby, A., Chalkiti, K., Morris, P., Carapetis, J., et al (2013). ABRACADABRA aids Indigenous and non-Indigenous early literacy in Australia: Evidence from a multisite randomized controlled trial. Computers and Education, 67, 250-264. [More Information]
  • Boekholdt, S., Arsenault, B., Hovingh, G., Mora, S., Pedersen, T., LaRosa, J., Welch, K., Amarenco, P., DeMicco, D., Tonkin, A., Sullivan, D., Kirby, A., et al (2013). Levels and Changes of HDL Cholesterol and Apolipoprotein A-I in Relation to Risk of Cardiovascular Events Among Statin-Treated Patients: A Meta-Analysis. Circulation, 128(14), 1504-1512. [More Information]
  • Stenson, B., Tarnow-Mordi, W., Darlow, B., Simes, R., Juszczak, E., Askie, L., Battin, M., Bowler, U., Broadbent, R., Cairns, P., Donoghoe, M., Ghadge, A., Hague, W., Kirby, A., et al (2013). Oxygen Saturation and Outcomes in Preterm Infants. The New England Journal of Medicine, 368(22), 2094-2104. [More Information]
  • Dietz, H., Franco, A., Shek, K., Kirby, A. (2012). Avulsion injury and levator hiatal ballooning: two independent risk factors for prolapse? An observational study. Acta Obstetricia et Gynecologica Scandinavica, 91, 211-214. [More Information]
  • Quinton, A., Peek, M., Cook, C., Kirby, A. (2012). Flow-Mediated Dilatation Assessment in Women with Preeclampsia Compared to Women with Gestational Hypertension. Hypertension in Pregnancy, 31(4), 377-386. [More Information]
  • Brighton, T., Eikelboom, J., Mann, K., Mister, R., Gallus, A., Ockelford, P., Gibbs, H., Hague, W., Xavier, D., Diaz, R., Kirby, A., Simes, R. (2012). Low-Dose Aspirin for Preventing Recurrent Venous Thromboembolism. The New England Journal of Medicine, 367(2), 1979-1987. [More Information]
  • Holsinger, D., Brown, R., Richmond, R., Kay-Lambkin, F., Kirby, A., Chan, D. (2012). Prevalence of the long-allele genotype of the serotonin transporter-linked gene in female centenarians. Journal of the American Geriatrics Society, 60(9), 1786-1788. [More Information]
  • Bell, K., Kirby, A., Hayen, A., Irwig, L., Glasziou, P. (2011). Monitoring adherence to drug treatment by using change in cholesterol concentration: secondary analysis of trial data. BMJ: British Medical Journal, 342(Issue 7791, 29 January 2011, Article number d12), 1-7. [More Information]
  • Quinton, A., Peek, M., Cook, C., Kirby, A. (2010). Flow-Mediated Dilatation Assessment in Women with Preeclampsia Compared to Women with Gestational Hypertension. Hypertension in Pregnancy, Online, 1-10. [More Information]
  • Dietz, H., Bernardo, M., Kirby, A., Shek, K. (2010). Minimal criteria for the diagnosis of avulsion of the puborectalis muscle by tomographic ultrasound. International Urogynecology Journal, 22(6), 699-704. [More Information]
  • Dietz, H., Kirby, A. (2010). Modelling the likelihood of levator avulsion in a urogynaecological population. Australian and New Zealand Journal of Obstetrics and Gynaecology, 50(3), 268-272. [More Information]
  • Cui, J., Forbes, A., Kirby, A., Marschner, C., Simes, R., Hunt, D., West, M., Tonkin, A. (2010). Semi-parametric risk prediction models for recurrent cardiovascular events in the LIPID study. BMC Medical Research Methodology, 10(27), 27-1-27-9. [More Information]
  • Shek, K., Dietz, H., Kirby, A. (2010). The Effect of Childbirth on Urethral Mobility: A Prospective Observational Study. The Journal of Urology, 184(2), 629-634. [More Information]
  • Chan, K., Chawantanpipat, C., Gattorna, T., Chantadansuwan, T., Kirby, A., Madden, A., Keech, A., Ng, M. (2010). The relationship between coronary stenosis severity and compression type coronary artery movement in acute myocardial infarction. American Heart Journal, 159(4), 584-592. [More Information]
  • Dietz, H., Kirby, A., Shek, K., Bedwell, P. (2009). Does avulsion of the puborectalis muscle affect bladder function? International Urogynecology Journal, 20(8), 967-972. [More Information]
  • Cui, J., Forbes, A., Kirby, A., Simes, R., Tonkin, A. (2009). Laboratory and non-laboratory-based risk prediction models for secondary prevention of cardiovascular disease: the LIPID study. European Journal of Cardiovascular Prevention and Rehabilitation, 16(6), 660-668. [More Information]
  • Huang, R., Torzillo, P., Hammond, V., Coulter, S., Kirby, A. (2008). Epidemiology of sexually transmitted infections on the Anangu Pitjantjatjara Yankunytjatjara Lands: results of a comprehensive control program. Medical Journal of Australia, 189(8), 442-445. [More Information]
  • Huang, R., Torzillo, P., Kirby, A. (2008). Epidemiology of sexually transmitted infections on the Anangu Pitjantjatjara Yankunytjatjara Lands: results of a comprehensive control program--a postscript. Medical Journal of Australia, 189(8), 446. [More Information]
  • Cui, J., Forbes, A., Kirby, A., Marschner, C., Simes, R., West, M., Tonkin, A. (2008). Parametric conditional frailty models for recurrent cardiovascular events in the lipid study. Clinical Trials, 5(6), 565-574. [More Information]
  • West, M., Nestel, P., Kirby, A., Schnabel, R., Sullivan, D., Simes, R., Pollicino, C., Lubos, E., Munzel, T., White, H., et al (2008). The value of N-terminal fragment of brain natriuretic peptide and tissue inhibitor of metalloproteinase-1 levels as predictors of cardiovascular outcome in the LIPID study. European Heart Journal, 29(7), 923-931. [More Information]
  • Tonkin, A., Eckermann, S., White, H., Friedlander, D., Glasziou, P., Magnus, P., Kirby, A., Mulray, S., Denton, M., Sallaberger, M., Simes, R., et al (2006). Cost-effectiveness of cholesterol-lowering therapy with pravastatin in patients with previous acute coronary syndromes aged 65 to 74 years compared with younger patients: results from the LIPID study. American Heart Journal, 151(6), 1305-1312. [More Information]
  • Atlantis, E., Chow, C., Kirby, A., Fiatarone Singh, M. (2006). Worksite intervention effects on physical health: a randomised controlled trial. Health Promotion International, 21(3), 191-200. [More Information]
  • Atlantis, E., Chow, C., Kirby, A., Fiatarone Singh, M. (2006). Worksite intervention effects on sleep quality: a randomized controlled trial. Journal of Occupational Health Psychology, 11(4), 291-304. [More Information]
  • West, M., Blankenberg, S., Simes, R., Pollicino, C., Kirby, A., Nestel, P., White, H., Tonkin, A. (2005). Brain natriuretic peptide: a predictor of cardiovascular outcome in the Long-term Intervention with Pravastatin in Ischaemic Disease (LIPID) study. European Heart Journal, 26(Suppl 1), 718-718.
  • Newman, R., Bryden, W., Kirby, A., Storlein, L., Downing, J. (2005). Dietary n-3 and n-6 fatty acids alter avian glucose metabolism. British Poultry Science, 46(1), 104-113.
  • Baigent, C., Keech, A., Kearney, P., Blackwell, L., Buck, G., Pollicino, C., Kirby, A., Sourjina, T., Peto, R., Collins, R., Simes, R. (2005). Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins. The Lancet, 366(9493), 1267-1278. [More Information]
  • Lee, C., Giles, L., Bryden, W., Downing, J., Owens, P., Kirby, A., Wynn, P. (2005). Performance and endocrine responses of group housed weaner pigs exposed to the air quality of a commercial environment. Livestock Science, 93(3), 255-262.
  • Nestel, P., Baghurst, K., Colquhoun, D., Simes, R., Mehalski, K., White, H., Tonkin, A., Kirby, A., Pollicino, C. (2005). Relation of diet to cardiovascular disease risk factors in subjects with cardiovascular disease in Australia and New Zealand: analysis of the Long-Term Intervention with Pravastatin in Ischaemic Disease trial. American Journal of Clinical Nutrition, 81(6), 1322-1329. [More Information]
  • Nestel, P., Blankenberg, S., Simes, R., Kirby, A., Tonkin, A. (2005). Tissue inhibitor of metalloproteinase (TIMP-1) is a predictor of recurrent cardiovascular events in the LIPID study. European Heart Journal, 26(Suppl 1), 257-257.
  • Stewart, R., White, H., Kirby, A., Heritier, S., Simes, R., Nestel, P., West, M., Colquhoun, D., Tonkin, A. (2005). White Blood Cell Count Predicts Reduction in Coronary Heart Disease Mortality With Pravastatin. Circulation, 111(14), 1756-1762. [More Information]
  • Atlantis, E., Chow, C., Kirby, A., Fiatarone Singh, M. (2004). An Effective Exercise-Based Intervention For Improving Mental Health And Quality Of Life Measures: A Randomized Controlled Trial. Preventive Medicine, 39(2), 424-434.
  • Magliano, D., Liew, D., Pater, H., Kirby, A., Hunt, D., Simes, R., Sundararajan, V., Tonkin, A. (2003). Accuracy of the Australian National Death Index: comparison with adjudicated fatal outcomes among Australian participants in the long-term intervention with Pravastatin in Ischaemic Disease (LIPID) Study. Australian and New Zealand Journal of Public Health, 27(6), 649-653. [More Information]
  • Kirby, A., Gebski, V., Keech, A. (2003). Determining the sample size in a clinical trial [in reply]. Medical Journal of Australia, 178(7), 358-358.
  • Newman, R., Storlien, L., Bryden, W., Kirby, A., Downing, J. (2003). Dietary n-3 and n-6 fatty acids alter avian pituitary sensitivity. Nutritional Neuroscience, 6(6), 343-350.
  • Keech, A., Colquhoun, D., Best, J., Kirby, A., Simes, R., Hunt, D., Hague, W., Beller, E., Arulchelvam, M., Baker, J., et al (2003). Secondary prevention of cardio vascular events with long-term Pravastatin in patients with diabetes or impared fasting glucose: results from the LIPID trial. Diabetes Care, 26(10), 2713-2721.
  • Glasziou, P., Eckermann, S., Mulray, S., Simes, R., Martin, A., Kirby, A., Hall, J., White, H., Caleo, S., Tonkin, A. (2002). Cholesterol-lowering therapy with pravastatin in patients with average cholesterol levels and establisheed ischaemic heart disease: is it cost effective? Medical Journal of Australia, 177(8), 428-434.
  • Kirby, A., Gebski, V., Keech, A. (2002). Determining the sample size in a clinical trial. Medical Journal of Australia, , 256-257.
  • Simes, R., Kirby, A., Keech, A., Hague, W., MacMahon, S., Hunt, D., Tonkin, A., Alyward, P., Colquhoun, D., Glasziou, P., et al (2002). Long-term effectiveness and safety of pravastatin in 9014 patients with coronary heart disease and average cholesterol concentrations: the LIPID trial follow up. The Lancet, 359, 1379-1387.
  • West, M., White, H., Simes, R., Kirby, A., Watson, J., Anderson, N., Hankey, G., Simes, S., Hunt, D., Tonkin, A. (2002). Risk factors for non-haemorraghic stroke in patients with coronary heart disease and the effect of lipid-modifying therapy with pravastatin. Journal of Hypertension, 20(12), 2513-2517.
  • Hoffmann, K., Wood, A., Griffiths, K., Evans, D., Gill, R., Kirby, A. (2001). Doppler sonographic measurements of arterial blood flow and their repeatability in the equine foot during weight-bearing and non weight bearing. Research In Veterinary Science, 70, 199-203.
  • Hoffman, K., Wood, A., Griffiths, K., Evans, D., Kirby, A., Gill,, R. (2001). Doppler sonographic measurements of arterial blood flow and their repeatability in the equine foot during weight-bearing and non-weight bearing. Research In Veterinary Science, 70, 199-203.
  • Hoffmann, K., Wood, A., Griffiths, K., Evans, D., Gill, R., Kirby, A. (2001). Postprandial arterial vasodilation in the equine distal thoracic limb. Equine Veterinary Journal, 33(3), 269-273.

Conferences

  • Atlantis, E., Kirby, A. (2006). Body mass index and behavioural factors associated with risk of depression among Australian adults. 10th International Congress on Obesity.
  • Colquhoun, D., Soderberg, S., Kirby, A., Keech, A., Simes, R., Hague, W., Hamilton-Craig, I., Tonkin, A. (2006). Obesity and adipokines as risk factors for major coronary heart disease events in patients with CHD: Results from the lipid trial. XIV International Symposium on Atherosclerosis, Ireland: Elsevier Ireland Ltd.
  • Eckermann, S., Kirby, A. (2004). Cost-effectiveness analysis: uncertainty, predictive conditioning and extrapolation post-study: results from LIPID. 24th Australian Conference of Health Economists, Sydney, NSW, Australia: Australian Health Economics Society.
  • Atlantis, E., Chow, C., Kirby, A., Fiatarone Singh, M. (2003). An effective exercise-based intervention for improving mental health and quality of life measures: A randomized controlled trial. American Public Health Association 131st Annual Meeting, United States: American Public Health Association.
  • Atlantis, E., Chow, C., Kirby, A., Fiatarone Singh, M. (2003). An effective exercise-based work-site health promotion intervention for improving body composition: A randomized controlled trial. American Public Health Association 131st Annual Meeting, United States: American Public Health Association.
  • Atlantis, E., Chow, C., Kirby, A., Fiatarone Singh, M. (2003). Hypothesized mechanisms of action for improving mental health post an effective exercise-based intervention: A randomized controlled trial. American Public Health Association 131st Annual Meeting, United States: American Public Health Association.
  • Atlantis, E., Chow, C., Kirby, A., Fiatarone Singh, M. (2003). Randomized controlled trial of a work-site exercise-based intervention: Effects on visceral and whole-body fat mass. Australasian Society for the Study of Obesity 12th Annual Scientific Meeting, Australia: Australasian Society for the Study of Obesity.

2014

  • Simes, R., Becattini, C., Agnelli, G., Eikelboom, J., Kirby, A., Mister, R., Prandoni, P., Brighton, T. (2014). Aspirin for the Prevention of Recurrent Venous Thromboembolism: The INSPIRE Collaboration. Circulation (Baltimore), 130(13), 1062-1071. [More Information]
  • Glasziou, P., Irwig, L., Kirby, A., Tonkin, A., Simes, R. (2014). Which lipid measurement should we monitor? An analysis of the LIPID study. BMJ Open, 4(2), e003512. [More Information]

2013

  • Wolgemuth, J., Savage, R., Helmer, J., Harper, H., Lea, T., Abrami, P., Kirby, A., Chalkiti, K., Morris, P., Carapetis, J., et al (2013). ABRACADABRA aids Indigenous and non-Indigenous early literacy in Australia: Evidence from a multisite randomized controlled trial. Computers and Education, 67, 250-264. [More Information]
  • Boekholdt, S., Arsenault, B., Hovingh, G., Mora, S., Pedersen, T., LaRosa, J., Welch, K., Amarenco, P., DeMicco, D., Tonkin, A., Sullivan, D., Kirby, A., et al (2013). Levels and Changes of HDL Cholesterol and Apolipoprotein A-I in Relation to Risk of Cardiovascular Events Among Statin-Treated Patients: A Meta-Analysis. Circulation, 128(14), 1504-1512. [More Information]
  • Stenson, B., Tarnow-Mordi, W., Darlow, B., Simes, R., Juszczak, E., Askie, L., Battin, M., Bowler, U., Broadbent, R., Cairns, P., Donoghoe, M., Ghadge, A., Hague, W., Kirby, A., et al (2013). Oxygen Saturation and Outcomes in Preterm Infants. The New England Journal of Medicine, 368(22), 2094-2104. [More Information]

2012

  • Dietz, H., Franco, A., Shek, K., Kirby, A. (2012). Avulsion injury and levator hiatal ballooning: two independent risk factors for prolapse? An observational study. Acta Obstetricia et Gynecologica Scandinavica, 91, 211-214. [More Information]
  • Quinton, A., Peek, M., Cook, C., Kirby, A. (2012). Flow-Mediated Dilatation Assessment in Women with Preeclampsia Compared to Women with Gestational Hypertension. Hypertension in Pregnancy, 31(4), 377-386. [More Information]
  • Brighton, T., Eikelboom, J., Mann, K., Mister, R., Gallus, A., Ockelford, P., Gibbs, H., Hague, W., Xavier, D., Diaz, R., Kirby, A., Simes, R. (2012). Low-Dose Aspirin for Preventing Recurrent Venous Thromboembolism. The New England Journal of Medicine, 367(2), 1979-1987. [More Information]
  • Holsinger, D., Brown, R., Richmond, R., Kay-Lambkin, F., Kirby, A., Chan, D. (2012). Prevalence of the long-allele genotype of the serotonin transporter-linked gene in female centenarians. Journal of the American Geriatrics Society, 60(9), 1786-1788. [More Information]

2011

  • Bell, K., Kirby, A., Hayen, A., Irwig, L., Glasziou, P. (2011). Monitoring adherence to drug treatment by using change in cholesterol concentration: secondary analysis of trial data. BMJ: British Medical Journal, 342(Issue 7791, 29 January 2011, Article number d12), 1-7. [More Information]

2010

  • Quinton, A., Peek, M., Cook, C., Kirby, A. (2010). Flow-Mediated Dilatation Assessment in Women with Preeclampsia Compared to Women with Gestational Hypertension. Hypertension in Pregnancy, Online, 1-10. [More Information]
  • Dietz, H., Bernardo, M., Kirby, A., Shek, K. (2010). Minimal criteria for the diagnosis of avulsion of the puborectalis muscle by tomographic ultrasound. International Urogynecology Journal, 22(6), 699-704. [More Information]
  • Dietz, H., Kirby, A. (2010). Modelling the likelihood of levator avulsion in a urogynaecological population. Australian and New Zealand Journal of Obstetrics and Gynaecology, 50(3), 268-272. [More Information]
  • Cui, J., Forbes, A., Kirby, A., Marschner, C., Simes, R., Hunt, D., West, M., Tonkin, A. (2010). Semi-parametric risk prediction models for recurrent cardiovascular events in the LIPID study. BMC Medical Research Methodology, 10(27), 27-1-27-9. [More Information]
  • Shek, K., Dietz, H., Kirby, A. (2010). The Effect of Childbirth on Urethral Mobility: A Prospective Observational Study. The Journal of Urology, 184(2), 629-634. [More Information]
  • Chan, K., Chawantanpipat, C., Gattorna, T., Chantadansuwan, T., Kirby, A., Madden, A., Keech, A., Ng, M. (2010). The relationship between coronary stenosis severity and compression type coronary artery movement in acute myocardial infarction. American Heart Journal, 159(4), 584-592. [More Information]

2009

  • Dietz, H., Kirby, A., Shek, K., Bedwell, P. (2009). Does avulsion of the puborectalis muscle affect bladder function? International Urogynecology Journal, 20(8), 967-972. [More Information]
  • Cui, J., Forbes, A., Kirby, A., Simes, R., Tonkin, A. (2009). Laboratory and non-laboratory-based risk prediction models for secondary prevention of cardiovascular disease: the LIPID study. European Journal of Cardiovascular Prevention and Rehabilitation, 16(6), 660-668. [More Information]

2008

  • Huang, R., Torzillo, P., Hammond, V., Coulter, S., Kirby, A. (2008). Epidemiology of sexually transmitted infections on the Anangu Pitjantjatjara Yankunytjatjara Lands: results of a comprehensive control program. Medical Journal of Australia, 189(8), 442-445. [More Information]
  • Huang, R., Torzillo, P., Kirby, A. (2008). Epidemiology of sexually transmitted infections on the Anangu Pitjantjatjara Yankunytjatjara Lands: results of a comprehensive control program--a postscript. Medical Journal of Australia, 189(8), 446. [More Information]
  • Cui, J., Forbes, A., Kirby, A., Marschner, C., Simes, R., West, M., Tonkin, A. (2008). Parametric conditional frailty models for recurrent cardiovascular events in the lipid study. Clinical Trials, 5(6), 565-574. [More Information]
  • West, M., Nestel, P., Kirby, A., Schnabel, R., Sullivan, D., Simes, R., Pollicino, C., Lubos, E., Munzel, T., White, H., et al (2008). The value of N-terminal fragment of brain natriuretic peptide and tissue inhibitor of metalloproteinase-1 levels as predictors of cardiovascular outcome in the LIPID study. European Heart Journal, 29(7), 923-931. [More Information]

2007

  • Keech, A., Gebski, V., Kirby, A. (2007). Determining the sample size in a clinical trial. In Anthony Keech, Val Gebski, Rhana Pike (Eds.), Interpreting and reporting clinical trials: a guide to the CONSORT statement and the principles of randomised controlled trials, (pp. 28-38). Sydney: AMPCo.

2006

  • Atlantis, E., Kirby, A. (2006). Body mass index and behavioural factors associated with risk of depression among Australian adults. 10th International Congress on Obesity.
  • Tonkin, A., Eckermann, S., White, H., Friedlander, D., Glasziou, P., Magnus, P., Kirby, A., Mulray, S., Denton, M., Sallaberger, M., Simes, R., et al (2006). Cost-effectiveness of cholesterol-lowering therapy with pravastatin in patients with previous acute coronary syndromes aged 65 to 74 years compared with younger patients: results from the LIPID study. American Heart Journal, 151(6), 1305-1312. [More Information]
  • Colquhoun, D., Soderberg, S., Kirby, A., Keech, A., Simes, R., Hague, W., Hamilton-Craig, I., Tonkin, A. (2006). Obesity and adipokines as risk factors for major coronary heart disease events in patients with CHD: Results from the lipid trial. XIV International Symposium on Atherosclerosis, Ireland: Elsevier Ireland Ltd.
  • Atlantis, E., Chow, C., Kirby, A., Fiatarone Singh, M. (2006). Worksite intervention effects on physical health: a randomised controlled trial. Health Promotion International, 21(3), 191-200. [More Information]
  • Atlantis, E., Chow, C., Kirby, A., Fiatarone Singh, M. (2006). Worksite intervention effects on sleep quality: a randomized controlled trial. Journal of Occupational Health Psychology, 11(4), 291-304. [More Information]

2005

  • West, M., Blankenberg, S., Simes, R., Pollicino, C., Kirby, A., Nestel, P., White, H., Tonkin, A. (2005). Brain natriuretic peptide: a predictor of cardiovascular outcome in the Long-term Intervention with Pravastatin in Ischaemic Disease (LIPID) study. European Heart Journal, 26(Suppl 1), 718-718.
  • Newman, R., Bryden, W., Kirby, A., Storlein, L., Downing, J. (2005). Dietary n-3 and n-6 fatty acids alter avian glucose metabolism. British Poultry Science, 46(1), 104-113.
  • Baigent, C., Keech, A., Kearney, P., Blackwell, L., Buck, G., Pollicino, C., Kirby, A., Sourjina, T., Peto, R., Collins, R., Simes, R. (2005). Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins. The Lancet, 366(9493), 1267-1278. [More Information]
  • Lee, C., Giles, L., Bryden, W., Downing, J., Owens, P., Kirby, A., Wynn, P. (2005). Performance and endocrine responses of group housed weaner pigs exposed to the air quality of a commercial environment. Livestock Science, 93(3), 255-262.
  • Nestel, P., Baghurst, K., Colquhoun, D., Simes, R., Mehalski, K., White, H., Tonkin, A., Kirby, A., Pollicino, C. (2005). Relation of diet to cardiovascular disease risk factors in subjects with cardiovascular disease in Australia and New Zealand: analysis of the Long-Term Intervention with Pravastatin in Ischaemic Disease trial. American Journal of Clinical Nutrition, 81(6), 1322-1329. [More Information]
  • Nestel, P., Blankenberg, S., Simes, R., Kirby, A., Tonkin, A. (2005). Tissue inhibitor of metalloproteinase (TIMP-1) is a predictor of recurrent cardiovascular events in the LIPID study. European Heart Journal, 26(Suppl 1), 257-257.
  • Stewart, R., White, H., Kirby, A., Heritier, S., Simes, R., Nestel, P., West, M., Colquhoun, D., Tonkin, A. (2005). White Blood Cell Count Predicts Reduction in Coronary Heart Disease Mortality With Pravastatin. Circulation, 111(14), 1756-1762. [More Information]

2004

  • Atlantis, E., Chow, C., Kirby, A., Fiatarone Singh, M. (2004). An Effective Exercise-Based Intervention For Improving Mental Health And Quality Of Life Measures: A Randomized Controlled Trial. Preventive Medicine, 39(2), 424-434.
  • Eckermann, S., Kirby, A. (2004). Cost-effectiveness analysis: uncertainty, predictive conditioning and extrapolation post-study: results from LIPID. 24th Australian Conference of Health Economists, Sydney, NSW, Australia: Australian Health Economics Society.

2003

  • Magliano, D., Liew, D., Pater, H., Kirby, A., Hunt, D., Simes, R., Sundararajan, V., Tonkin, A. (2003). Accuracy of the Australian National Death Index: comparison with adjudicated fatal outcomes among Australian participants in the long-term intervention with Pravastatin in Ischaemic Disease (LIPID) Study. Australian and New Zealand Journal of Public Health, 27(6), 649-653. [More Information]
  • Atlantis, E., Chow, C., Kirby, A., Fiatarone Singh, M. (2003). An effective exercise-based intervention for improving mental health and quality of life measures: A randomized controlled trial. American Public Health Association 131st Annual Meeting, United States: American Public Health Association.
  • Atlantis, E., Chow, C., Kirby, A., Fiatarone Singh, M. (2003). An effective exercise-based work-site health promotion intervention for improving body composition: A randomized controlled trial. American Public Health Association 131st Annual Meeting, United States: American Public Health Association.
  • Kirby, A., Gebski, V., Keech, A. (2003). Determining the sample size in a clinical trial [in reply]. Medical Journal of Australia, 178(7), 358-358.
  • Newman, R., Storlien, L., Bryden, W., Kirby, A., Downing, J. (2003). Dietary n-3 and n-6 fatty acids alter avian pituitary sensitivity. Nutritional Neuroscience, 6(6), 343-350.
  • Atlantis, E., Chow, C., Kirby, A., Fiatarone Singh, M. (2003). Hypothesized mechanisms of action for improving mental health post an effective exercise-based intervention: A randomized controlled trial. American Public Health Association 131st Annual Meeting, United States: American Public Health Association.
  • Atlantis, E., Chow, C., Kirby, A., Fiatarone Singh, M. (2003). Randomized controlled trial of a work-site exercise-based intervention: Effects on visceral and whole-body fat mass. Australasian Society for the Study of Obesity 12th Annual Scientific Meeting, Australia: Australasian Society for the Study of Obesity.
  • Keech, A., Colquhoun, D., Best, J., Kirby, A., Simes, R., Hunt, D., Hague, W., Beller, E., Arulchelvam, M., Baker, J., et al (2003). Secondary prevention of cardio vascular events with long-term Pravastatin in patients with diabetes or impared fasting glucose: results from the LIPID trial. Diabetes Care, 26(10), 2713-2721.

2002

  • Glasziou, P., Eckermann, S., Mulray, S., Simes, R., Martin, A., Kirby, A., Hall, J., White, H., Caleo, S., Tonkin, A. (2002). Cholesterol-lowering therapy with pravastatin in patients with average cholesterol levels and establisheed ischaemic heart disease: is it cost effective? Medical Journal of Australia, 177(8), 428-434.
  • Kirby, A., Gebski, V., Keech, A. (2002). Determining the sample size in a clinical trial. Medical Journal of Australia, , 256-257.
  • Simes, R., Kirby, A., Keech, A., Hague, W., MacMahon, S., Hunt, D., Tonkin, A., Alyward, P., Colquhoun, D., Glasziou, P., et al (2002). Long-term effectiveness and safety of pravastatin in 9014 patients with coronary heart disease and average cholesterol concentrations: the LIPID trial follow up. The Lancet, 359, 1379-1387.
  • West, M., White, H., Simes, R., Kirby, A., Watson, J., Anderson, N., Hankey, G., Simes, S., Hunt, D., Tonkin, A. (2002). Risk factors for non-haemorraghic stroke in patients with coronary heart disease and the effect of lipid-modifying therapy with pravastatin. Journal of Hypertension, 20(12), 2513-2517.

2001

  • Hoffmann, K., Wood, A., Griffiths, K., Evans, D., Gill, R., Kirby, A. (2001). Doppler sonographic measurements of arterial blood flow and their repeatability in the equine foot during weight-bearing and non weight bearing. Research In Veterinary Science, 70, 199-203.
  • Hoffman, K., Wood, A., Griffiths, K., Evans, D., Kirby, A., Gill,, R. (2001). Doppler sonographic measurements of arterial blood flow and their repeatability in the equine foot during weight-bearing and non-weight bearing. Research In Veterinary Science, 70, 199-203.
  • Hoffmann, K., Wood, A., Griffiths, K., Evans, D., Gill, R., Kirby, A. (2001). Postprandial arterial vasodilation in the equine distal thoracic limb. Equine Veterinary Journal, 33(3), 269-273.

To update your profile click here. For support on your academic profile contact .